{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:02:52Z","timestamp":1790751772420,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1135-1","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T14:22:05Z","timestamp":1443622925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genotypic distribution and hepatic fibrosis among HIV\/HCV co-infected individuals in Southern China: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"15","author":[{"given":"Kali","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie P.","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"issue":"4","key":"1135_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","volume":"156","author":"KN Ly","year":"2012","unstructured":"Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1135_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1086\/321819","volume":"33","author":"HK Monga","year":"2001","unstructured":"Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;33(2):240\u20137.","journal-title":"Clin Infect Dis"},{"key":"1135_CR3","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin C, Friis-M\u00f8ller N, for the The Data Collection on Adverse Events of Anti-HIV Drugs Study Group, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med. 2006;166:1632\u201341.","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"1135_CR4","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/cid\/cis367","volume":"55","author":"LE Taylor","year":"2012","unstructured":"Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012;55 Suppl 1:S33\u201342.","journal-title":"Clin Infect Dis"},{"key":"1135_CR5","unstructured":"China MoHotPsRo. 2012 China AIDS response progress report. In. Edited by China MoHotPsRo. China; 2012."},{"issue":"1 Suppl","key":"1135_CR6","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45\u201357.","journal-title":"J Hepatol"},{"issue":"11","key":"1135_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","volume":"14","author":"F Zhang","year":"2014","unstructured":"Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010\u201312: a retrospective observational cohort study. Lancet Infect Dis. 2014;14(11):1065\u201372.","journal-title":"Lancet Infect Dis"},{"issue":"9651","key":"1135_CR8","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet"},{"issue":"9791","key":"1135_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571\u201383.","journal-title":"Lancet"},{"issue":"1","key":"1135_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00002030-200001070-00009","volume":"14","author":"C Beyrer","year":"2000","unstructured":"Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. Aids. 2000;14(1):75\u201383.","journal-title":"Aids"},{"issue":"Suppl 1","key":"1135_CR11","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1086\/429491","volume":"41","author":"RJ Garten","year":"2005","unstructured":"Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis. 2005;41 Suppl 1:S18\u201324.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1135_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1258\/ijsa.2008.008362","volume":"20","author":"YP Bao","year":"2009","unstructured":"Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009;20(6):399\u2013405.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"1135_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1468-1293.2012.01048.x","volume":"14","author":"YZ Shen","year":"2013","unstructured":"Shen YZ, Wang ZY, Qi TK, Jiang XY, Song W, Tang Y, et al. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV\/AIDS in China. HIV Med. 2013;14(3):167\u201375.","journal-title":"HIV Med"},{"issue":"4","key":"1135_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Macias","year":"2009","unstructured":"Macias J, Berenguer J, Japon MA, Giron JA, Rivero A, Lopez-Cortes LF, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology. 2009;50(4):1056\u201363.","journal-title":"Hepatology"},{"issue":"6","key":"1135_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1365-2893.2009.01197.x","volume":"17","author":"T Reiberger","year":"2010","unstructured":"Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, et al. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension. J Viral Hepat. 2010;17(6):400\u20139.","journal-title":"J Viral Hepat"},{"issue":"4","key":"1135_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/gut.51.4.601","volume":"51","author":"AH Mohsen","year":"2002","unstructured":"Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut. 2002;51(4):601\u20138.","journal-title":"Gut"},{"issue":"1","key":"1135_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.20541","volume":"41","author":"SH Mehta","year":"2005","unstructured":"Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, et al. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology. 2005;41(1):123\u201331.","journal-title":"Hepatology"},{"issue":"3","key":"1135_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/QAI.0000000000000156","volume":"66","author":"J Berenguer","year":"2014","unstructured":"Berenguer J, Zamora FX, Carrero A, Von Wichmann MA, Crespo M, Lopez-Aldeguer J, et al. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis. J Acquir Immune Defic Syndr. 2014;66(3):280\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"1135_CR19","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1097\/01.aids.0000247583.38943.95","volume":"20","author":"V Soriano","year":"2006","unstructured":"Soriano V, Labarga P, Ruiz-Sancho A, Garcia-Samaniego J, Barreiro P. Regression of liver fibrosis in hepatitis C virus\/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin. Aids. 2006;20(17):2225\u20137.","journal-title":"Aids"},{"issue":"9973","key":"1135_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(14)62483-1","volume":"385","author":"J-M Molina","year":"2015","unstructured":"Molina J-M, Orkin C, Iser DM, Zamora F-X, Nelson M, Stephan C, et al. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet. 2015;385(9973):1098\u2013106.","journal-title":"Lancet"},{"issue":"12","key":"1135_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.2015.1328","volume":"313","author":"MS Sulkowski","year":"2015","unstructured":"Sulkowski MS, Eron JJ, Wyles D, Trinh R, Lalezari J, Wang C, et al. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA. 2015;313(12):1223\u201331.","journal-title":"JAMA"},{"issue":"1\u20132","key":"1135_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","volume":"93","author":"J Grebely","year":"2008","unstructured":"Grebely J, Genoway KA, Raffa JD, Dhadwal G, Rajan T, Showler G, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend. 2008;93(1\u20132):141\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1135_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3851\/IMP1831","volume":"16","author":"T Reiberger","year":"2011","unstructured":"Reiberger T, Obermeier M, Payer BA, Baumgarten A, Weitner L, Moll A, et al. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting. Antivir Ther. 2011;16(6):815\u201324.","journal-title":"Antivir Ther"},{"issue":"suppl 1","key":"1135_CR24","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/cid\/cis361","volume":"55","author":"FM Averhoff","year":"2012","unstructured":"Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55 suppl 1:S10\u20135.","journal-title":"Clin Infect Dis"},{"key":"1135_CR25","unstructured":"United Nations. Population distribution, urbanization, internal migration and development: an international perspective. In. Edited by Department of Economic and Social Affairs PD. New York, NY; 2011."},{"issue":"Suppl 8","key":"1135_CR26","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/01.aids.0000304710.10036.2b","volume":"21","author":"F Zhang","year":"2007","unstructured":"Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, et al. The Chinese free antiretroviral treatment program: challenges and responses. Aids. 2007;21 Suppl 8:S143\u20138.","journal-title":"Aids"},{"issue":"2","key":"1135_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C Wai","year":"2003","unstructured":"Wai C, Greenson J, Fontana R, Kalbfleisch J, Marrero J, Conjeevaram H, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"1","key":"1135_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Malet V, Nalpas B, Verkarre V, Nalpas A, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest. Hepatology. 2007;46(1):32\u20136.","journal-title":"Hepatology"},{"issue":"11","key":"1135_CR29","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1128\/JCM.41.11.5240-5244.2003","volume":"41","author":"KS Lole","year":"2003","unstructured":"Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5\u2032 noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003;41(11):5240\u20134.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1135_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jmv.20307","volume":"75","author":"L Lu","year":"2005","unstructured":"Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol. 2005;75(4):538\u201349.","journal-title":"J Med Virol"},{"issue":"3","key":"1135_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0006-291X(90)90494-8","volume":"170","author":"N Enomoto","year":"1990","unstructured":"Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990;170(3):1021\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1135_CR32","unstructured":"IBM Corporation. IBM SPSS statistics for windows. In., 20.0 edn. Armonk, NY (USA); 2011."},{"key":"1135_CR33","unstructured":"R Development Core Team. R: a language and environment for statistical computing. In. Edited by R Foundation for Statistical Computing. Vienna, Austria; 2003."},{"key":"1135_CR34","unstructured":"StataCorp. Stata statistical software. In., vol. 12. College Station, TX: StataCorp LP; 2011."},{"issue":"Suppl 1","key":"1135_CR35","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/infdis\/jis928","volume":"207","author":"J Grebely","year":"2013","unstructured":"Grebely J, Oser M, Taylor LE, Dore GJ. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels. J Infect Dis. 2013;207 Suppl 1:S19\u201325.","journal-title":"J Infect Dis"},{"issue":"8","key":"1135_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043141","volume":"7","author":"T Hammett","year":"2012","unstructured":"Hammett T, Des Jarlais D, Kling R, Kieu B, McNicholl J, Wasinrapee P, et al. Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China. PLoS One. 2012;7(8), e43141.","journal-title":"PLoS One"},{"issue":"suppl 8","key":"1135_CR37","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/01.aids.0000304706.79541.ef","volume":"21","author":"ZY Wu","year":"2007","unstructured":"Wu ZY, Luo W, Sullivan SG, Rou K, Lin P, Liu W, et al. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS. 2007;21 suppl 8:S115\u201322.","journal-title":"AIDS"},{"issue":"2","key":"1135_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jsat.2009.09.002","volume":"38","author":"CQ Lin","year":"2010","unstructured":"Lin CQ, Wu ZY, Rou KM, Yin WY, Wang CH, Shoptaw S, et al. Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J Subst Abuse Treat. 2010;38(2):119\u201335.","journal-title":"J Subst Abuse Treat"},{"key":"1135_CR39","doi-asserted-by":"publisher","first-page":"ii29","DOI":"10.1093\/ije\/dyq210","volume":"39","author":"WY Yin","year":"2010","unstructured":"Yin WY, Hao Y, Sun XH, Gong XL, Li F, Li J, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010;39:ii29\u201337.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1135_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068906","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chow EP, Zhuang X, Liang Y, Wang Y, Tang C, et al. Methadone maintenance treatment participant retention and behavioural effectiveness in china: a systematic review and meta-analysis. PLoS One. 2013;8(7), e68906.","journal-title":"PLoS One"},{"issue":"6","key":"1135_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066787","volume":"8","author":"Y-H Xia","year":"2013","unstructured":"Xia Y-H, McLaughlin MM, Chen W, Ling L, Tucker JD. HIV and hepatitis C virus testing delays at methadone clinics in Guangdong province, china. PLoS One. 2013;8(6), e66787.","journal-title":"PLoS One"},{"issue":"10","key":"1135_CR42","first-page":"729","volume":"19","author":"WL Chen","year":"2011","unstructured":"Chen WL, Nie JM, Cai WP, Yuan XZ, Hu FY, Wei SJ, et al. Analysis of hepatitis C virus (HCV) subtypes in HIV\/HCV co-infected and HCV mono-infected individuals in Guangdong province. Zhonghua Gan Zang Bing Za Zhi. 2011;19(10):729\u2013933.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"1135_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2893.2010.01280.x","volume":"18","author":"Y Fu","year":"2011","unstructured":"Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, et al. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat. 2011;18(1):42\u201352.","journal-title":"J Viral Hepat"},{"key":"1135_CR44","doi-asserted-by":"crossref","unstructured":"Rong X, Xu R, Xiong H, Wang M, Huang K, Chen Q, et al. Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004\u20132007 and 2008\u20132011. Arch Virol. 2014;159(12):3231-7.","DOI":"10.1007\/s00705-014-2185-1"},{"issue":"3","key":"1135_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2036.2011.04714.x","volume":"34","author":"DT Chao","year":"2011","unstructured":"Chao DT, Abe K, Nguyen MH. Systematic review: epidemiology of hepatitis C genotype 6 and its management. Aliment Pharmacol Ther. 2011;34(3):286\u201396.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1135_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2893.2010.01373.x","volume":"18","author":"YQ Zhou","year":"2011","unstructured":"Zhou YQ, Wang XH, Hong GH, Zhu Y, Zhang XQ, Hu YJ, et al. Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a. J Viral Hepat. 2011;18(8):595\u2013600.","journal-title":"J Viral Hepat"},{"issue":"3","key":"1135_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1053\/j.gastro.2011.06.004","volume":"141","author":"JM Gottwein","year":"2011","unstructured":"Gottwein JM, Scheel TK, Jensen TB, Ghanem L, Bukh J. Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3\/4A protease recombinant viruses. Gastroenterology. 2011;141(3):1067\u201379.","journal-title":"Gastroenterology"},{"issue":"9883","key":"1135_CR48","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(13)60247-0","volume":"381","author":"KV Kowdley","year":"2013","unstructured":"Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, DeMicco M, et al. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet. 2013;381(9883):2100\u20137.","journal-title":"Lancet"},{"issue":"7","key":"1135_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101760","volume":"9","author":"S Corchado","year":"2014","unstructured":"Corchado S, Lopez-Cortes LF, Rivero-Juarez A, Torres-Cornejo A, Rivero A, Marquez-Coello M, et al. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV\/HCV coinfected patients. PLoS One. 2014;9(7), e101760.","journal-title":"PLoS One"},{"issue":"9","key":"1135_CR50","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/cir071","volume":"52","author":"M Mendeni","year":"2011","unstructured":"Mendeni M, Foca E, Gotti D, Ladisa N, Angarano G, Albini L, et al. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis. 2011;52(9):1164\u201373.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1135_CR51","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/jvh.12168","volume":"20","author":"EB Tapper","year":"2013","unstructured":"Tapper EB, Afdhal NH. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3. J Viral Hepat. 2013;20(10):669\u201377.","journal-title":"J Viral Hepat"},{"issue":"1","key":"1135_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jhep.2005.01.031","volume":"43","author":"A Gordon","year":"2005","unstructured":"Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005;43(1):38\u201344.","journal-title":"J Hepatol"},{"issue":"3","key":"1135_CR53","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2013.11.009","volume":"146","author":"Y-P Li","year":"2014","unstructured":"Li Y-P, Ramirez S, Humes D, Jensen SB, Gottwein JM, Bukh J. Differential Sensitivity of 5\u2019UTR-NS5A Recombinants of Hepatitis C Virus Genotypes 1\u20136 to Protease and NS5A Inhibitors. Gastroenterology. 2014;146(3):812\u201321. e814.","journal-title":"Gastroenterology"},{"issue":"20","key":"1135_CR54","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","volume":"368","author":"IM Jacobson","year":"2013","unstructured":"Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med. 2013;368(20):1867\u201377.","journal-title":"N Engl J Med"},{"issue":"1","key":"1135_CR55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/ije\/dyh019","volume":"33","author":"RJ Garten","year":"2004","unstructured":"Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33(1):182\u20138.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1135_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101241","volume":"9","author":"C Dong","year":"2014","unstructured":"Dong C, Huang ZJ, Martin MC, Huang J, Liu H, Deng B, et al. The impact of social factors on human immunodeficiency virus and hepatitis C virus co-infection in a minority region of Si-chuan, the People\u2019s Republic of China: a population-based survey and testing study. PLoS One. 2014;9(7), e101241.","journal-title":"PLoS One"},{"issue":"6","key":"1135_CR57","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38(6):1449\u201357.","journal-title":"Hepatology"},{"issue":"10","key":"1135_CR58","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1007\/s10620-011-1710-2","volume":"56","author":"A Shah","year":"2011","unstructured":"Shah A, Smith P, Sterling R. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci. 2011;56(10):3038\u201344.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"1135_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74\u201381.","journal-title":"Liver Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1135-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:31:43Z","timestamp":1498249903000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1135-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1135-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]},"article-number":"401"}}